Turku Bioscience Centre
- Real-time acid production and extracellular matrix formation in mature biofilms of three Streptococcus mutans strains with special reference to xylitol (2024)
- Recent Advances and Impact of Chemotherapeutic and Antiangiogenic Nanoformulations for Combination Cancer Therapy (2020)
- Recent advances in immune checkpoint therapy in non-small cell lung cancer and opportunities for nanoparticle-based therapy (2021)
- Recent advances towards mass spectrometry-based clinical lipidomics (2023)
- Receptor-Mediated Surface Charge Inversion Platform Based on Porous Silicon Nanoparticles for Efficient Cancer Cell Recognition and Combination Therapy (2017)
- Receptor tyrosine kinase profiling of ischemic heart identifies ROR1 as a potential therapeutic target (2018)
- Recombination Monophosphoryl Lipid A-Derived Vacosome for the Development of Preventive Cancer Vaccines (2020)
- Recurrent cancer-associated ERBB4 mutations are transforming and confer resistance to targeted therapies (2025)
- Redox-Activated Signal Transduction Pathways Mediating Cellular Functions in Inflammation, Differentiation, Degeneration, Transformation, and Death (2016)
- REG4 Is Highly Expressed in Mucinous Ovarian Cancer: A Potential Novel Serum Biomarker (2016)





